This Top Penny Stock Could Double Thanks to Its Coronavirus Vaccine

The coronavirus hasn't hurt the markets like the mainstream media thought it would. And it still won't.

The Dow closed Friday over 600 points in the red on worries of the new coronavirus epidemic. But suddenly, it's back with a more than 150-point rally.

As usual, Wall Street lost grip of reality for a moment, then gained some of it back. This showed us again that there are always opportunities in the stock market, even when it looks like a world on fire.

Our top penny stock today is poised to not only survive the coronavirus, but break out with 136% gain from its eradication.

This is a heartbreaking situation around the world with more than 17,000 cases and over 300 deaths. But authorities are still trying to see if the death rate is enough to call it a pandemic just yet.

The fatality rate is still around 3%, less than MERS, which killed one in three, and SARS, which killed about one in 10.

But Wall Street seemed to forget that there is more to the market than travel and casinos (the industries most affected by the outbreak).

Historic FDA Approval: This biotech just received FDA approval for a first-of-its-kind treatment for a growing health crisis. There’s still time to get in on the biggest gains – if you act fast. Click here to get this FREE pick now.

There is still hope for reining in the coronavirus. In fact, the top penny stock to buy today is ready to double on efforts to stop its spread.

The White House recently fast-tracked the coronavirus vaccine, hoping for first-stage trials in as little as three months. China has also enlisted pharmaceutical companies to get the job done.

If trials succeed and a successful vaccine is eventually carried out, Wall Street may react just as quickly as it did on news of the outbreak - but this time positively.

A year was reported as the minimum time it will take to develop a vaccine. And that silver lining is reflected in the 12-month target for our top penny stock.

But even as fears continue to weigh the market down, this stock is poised to more than double.

Why This Penny Stock Could Double

You see, when one of the best penny stocks to buy gets a catalyst, it's likely more than a simple 30% to 40% profit for investors. Because penny stocks trade under $5, small changes amount to huge percentage gains.

That's why the top penny stocks today are more likely to double or triple on big news.

For example, one of our top penny stocks last year, General Moly Inc. (NYSE: GMO), soared 107% in a single week just because uncertainty ran high on the China trade war and the volatility index (VIX) ramped up.

Well, the VIX has climbed from 12 to 18 since the coronavirus began. And this penny stock is going to see a big swing in the positive direction.

The Best Penny Stock This Week

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Inovio Pharmaceuticals Inc. (NASDAQ: INO) develops immunotherapy technologies to prevent infectious diseases and cancer.

Immunotherapy is the practice of using the body's own immune system to fight its diseases. Vaccination falls into this category.

And Inovio, a Pennsylvania-based pharmaceutical, is one of many companies that has been tasked with finding a coronavirus vaccine.

It has already started preclinical testing and preparations to devise a vaccine in China.

Its stock jumped 12% on Jan. 23, when it won a $9 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI). But it still has further to go.

If it can advance the coronavirus vaccine successfully, that would bring it closer to the cutting edge in the immunotherapy market.

Inovio has already shown some impressive success on that front, taking a Zika virus to successful human testing in as little as seven months.

It's already begun testing a vaccine on animals as of Jan. 11. And CEO Joseph Kim expects to have human trials "before early summer."

With Inovio taking center stage in immunotherapy, analysts predict sales growth of 205% in the coming year.

And that's expected to translate to a 136% gain for today's investor, with the stock soaring from $3.99 to $9.43 a share.

You Can Collect Four Separate Paydays in Under a Minute with This Options Trading Secret

Live on camera, America's No. 1 Pattern Trader is showing you the secret behind some of his biggest trades to date.

Watch as he uses this special tool to collect four separate paydays in under a minute - all from enormous companies like Netflix, Apple, Facebook, even Amazon.

While it may have taken Tom years to invent this moneymaking "machine," it's super easy to understand and utilize.

All it takes is a few simple mouse clicks, and you could be hundreds, even thousands, richer.

This is an opportunity you won't want to miss out on.

Click here to get started today.

Follow Money Morning onFacebook and Twitter.